"Antibody Specificity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site.
| Descriptor ID |
D000918
|
| MeSH Number(s) |
G12.100
|
| Concept/Terms |
Antibody Specificity- Antibody Specificity
- Antibody Specificities
- Specificities, Antibody
- Specificity, Antibody
|
Below are MeSH descriptors whose meaning is more general than "Antibody Specificity".
Below are MeSH descriptors whose meaning is more specific than "Antibody Specificity".
This graph shows the total number of publications written about "Antibody Specificity" by people in this website by year, and whether "Antibody Specificity" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 8 | 8 |
| 1995 | 0 | 9 | 9 |
| 1996 | 1 | 7 | 8 |
| 1997 | 0 | 6 | 6 |
| 1998 | 0 | 13 | 13 |
| 1999 | 0 | 10 | 10 |
| 2000 | 1 | 12 | 13 |
| 2001 | 0 | 10 | 10 |
| 2002 | 0 | 9 | 9 |
| 2003 | 0 | 10 | 10 |
| 2004 | 1 | 5 | 6 |
| 2005 | 1 | 9 | 10 |
| 2006 | 0 | 4 | 4 |
| 2007 | 1 | 6 | 7 |
| 2008 | 1 | 6 | 7 |
| 2009 | 1 | 3 | 4 |
| 2010 | 1 | 6 | 7 |
| 2011 | 1 | 3 | 4 |
| 2012 | 0 | 3 | 3 |
| 2013 | 1 | 12 | 13 |
| 2014 | 0 | 5 | 5 |
| 2015 | 0 | 5 | 5 |
| 2016 | 1 | 4 | 5 |
| 2017 | 0 | 2 | 2 |
| 2018 | 0 | 7 | 7 |
| 2019 | 0 | 4 | 4 |
| 2021 | 0 | 5 | 5 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antibody Specificity" by people in Profiles.
-
The Trypanosoma cruzi Antigen and Epitope Atlas: antibody specificities in Chagas disease patients across the Americas. Nat Commun. 2023 04 03; 14(1):1850.
-
Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries. MAbs. 2022 Jan-Dec; 14(1):2002236.
-
mAb Das-1 recognizes 3'-Sulfated Lewis A/C, which is aberrantly expressed during metaplastic and oncogenic transformation of several gastrointestinal Epithelia. PLoS One. 2021; 16(12):e0261082.
-
Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding protein. Cell Rep. 2021 08 31; 36(9):109628.
-
Ebola vaccine-induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effects. Sci Transl Med. 2021 07 14; 13(602).
-
Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies. Cell Rep. 2021 04 13; 35(2):108984.
-
Antibody affinity versus dengue morphology influences neutralization. PLoS Pathog. 2021 02; 17(2):e1009331.
-
Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes. Cell Rep. 2020 10 27; 33(4):108322.
-
Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy. Cancer Cell. 2019 08 12; 36(2):168-178.e4.
-
Comprehensive Profiling of HIV Antibody Evolution. Cell Rep. 2019 04 30; 27(5):1422-1433.e4.